Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Surgical Wound Infection 4Neoplasms 4Colorectal Neoplasms 3Rectal Neoplasms 2Pancreatic Neoplasms 2Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Skin Neoplasms 1Sepsis 1Pancreatic Fistula 1Neutropenia 1Neoplasms, Plasma Cell 1Multiple Myeloma 1Multiple Endocrine Neoplasia Type 1 1Melanoma 1Lymphoma 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia 1Intestinal Neoplasms 1Inflammation 1Infections 1Hematologic Neoplasms 1Glioblastoma 1Fever 1Febrile Neutropenia 1Exanthema 1Emergencies 1Duodenal Neoplasms 1Discitis 1

Interventions

Carboplatin 340Cisplatin 238Paclitaxel 203Radiotherapy 195Pemetrexed 187Docetaxel 169Gemcitabine 157pembrolizumab 141Erlotinib Hydrochloride 107Etoposide 99Magnetic Resonance Spectroscopy 93Bevacizumab 91Specimen Handling 76Nivolumab 73Radiosurgery 72durvalumab 69Vinorelbine 54osimertinib 53Gefitinib 49Drug Therapy 49atezolizumab 42Irinotecan 42Radiation 40Topotecan 39Biopsy 39Standard of Care 38Cyclophosphamide 38Cetuximab 35Blood Specimen Collection 33Taxes 32

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Lung Neoplasms × Anti-Bacterial Agents × Clear all
NCT05502913 2023-10-02

Fecal Microbiota Transplantation With Immune Checkpoint Inhibitors in Lung Cancer

Soroka University Medical Center

Phase 2 Recruiting
80 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡